Form 4: STERIS plc Executive Acquires Shares and Options
SEC Form 4 Filing
Mary Clare Fraser, SVP & Chief HRO of STERIS plc, reports acquisition of shares and options.
Summary
- On June 4, 2024, Mary Clare Fraser, SVP & Chief HRO of STERIS plc, acquired 2,040 ordinary shares at $0 and 10,456 employee stock options at a price of $251.34.
- Following the transaction, Fraser directly owns 11,132 ordinary shares, including 8,909 restricted shares.
- The restricted shares vest over time, with 1,836 vesting on June 2, 2025; 692 on October 1, 2025; 2,313 on June 1, 2026; 2,028 on June 2, 2026 and 2,040 on June 4, 2027.
- The employee stock options become exercisable in installments: 2,614 on June 4, 2025; 2,614 on June 4, 2026; 2,614 on June 4, 2027 and 2,614 on June 5, 2028.
- Following the transaction, Fraser directly owns 10,456 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing indicating insider transactions, which doesn't inherently suggest positive or negative implications for the company's performance.
Positives
- The acquisition of shares and options by a company executive can be seen as a positive sign of confidence in the company's future.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives.
Stakeholder Impact
- Shareholders may view this as a sign of confidence from a company executive.
- Employees may see this as a positive indicator of company stability.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of transaction: Acquisition of ordinary shares and employee stock options. |
| 06/02/2025 | Vesting date for 1,836 restricted ordinary shares. |
| 10/01/2025 | Vesting date for 692 restricted ordinary shares. |
| 06/04/2025 | First exercisable date for 2,614 employee stock options. |
| 06/01/2026 | Vesting date for 2,313 restricted ordinary shares. |
| 06/02/2026 | Vesting date for 2,028 restricted ordinary shares. |
| 06/04/2026 | Second exercisable date for 2,614 employee stock options. |
| 06/04/2027 | Vesting date for 2,040 restricted ordinary shares. |
| 06/04/2027 | Third exercisable date for 2,614 employee stock options. |
| 06/05/2028 | Final exercisable date for 2,614 employee stock options. |
| 06/04/2034 | Expiration date for employee stock options. |
| 06/06/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.